title: Insulin Pump Malfunction During Hospitalization: Two Case Reports.
abstract: Insulin pump malfunctions and failures continue to occur; however, more severe malfunctions such as the "runaway pump" phenomenon are rarely reported. This article describes two cases of pump malfunction in which pump users appear to have received an unsolicited bolus of insulin resulting in severe episodes of hypoglycemia during hospitalization.
  
  
  
  Both cases of insulin pump malfunction occurred in the inpatient setting at a large academic medical center in the United States. An analysis of the corresponding insulin pump downloads was performed. The Food and Drug Administration's (FDA's) Manufacturer and User Facility Device Experience (MAUDE) database was searched for similar cases involving Medtronic (Northridge, CA) insulin pumps using the terms "pump," "infusion," "insulin AND malfunction AND Medtronic."
  
  
  
  The two cases described show remarkable similarities, each demonstrating a severe hypoglycemic event preceded by an infusion site change followed by an alarm. In both cases a rapid spraying of insulin was reported. The insulin pump downloads validated much of the patients' and medical staff's descriptions of events. The FDA's MAUDE database search revealed 425 cases meeting our search term criteria. All cases were reviewed. Seven cases were identified involving independent movement of the reservoir piston.
  
  
  
  The cases detailed are the first to describe an insulin pump malfunction of this nature in the hospital setting involving unsolicited insulin boluses leading to severe hypoglycemia. The cases are particularly compelling in that they were witnessed by medical personnel. Providers and patients should receive instruction education on the recognition and management of insulin pump malfunction.
authors.affiliation: 1 Division of Endocrinology, Diabetes & Metabolism, The Ohio State University College of Medicine , Columbus, Ohio.|2 The Ohio State University College of Nursing , Columbus, Ohio.
authors.forename: Eileen R
authors.initials: ER
authors.lastname: Faulds
authors.affiliation: 1 Division of Endocrinology, Diabetes & Metabolism, The Ohio State University College of Medicine , Columbus, Ohio.
authors.forename: Kathleen L
authors.initials: KL
authors.lastname: Wyne
authors.affiliation: 1 Division of Endocrinology, Diabetes & Metabolism, The Ohio State University College of Medicine , Columbus, Ohio.
authors.forename: Elizabeth O
authors.initials: EO
authors.lastname: Buschur
authors.affiliation: 2 The Ohio State University College of Nursing , Columbus, Ohio.
authors.forename: Jodi
authors.initials: J
authors.lastname: McDaniel
authors.affiliation: 1 Division of Endocrinology, Diabetes & Metabolism, The Ohio State University College of Medicine , Columbus, Ohio.
authors.forename: Kathleen
authors.initials: K
authors.lastname: Dungan
mesh_terms: D000328:Adult; D056902:Clinical Alarms; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy; D004868:Equipment Failure; D005260:Female; D006760:Hospitalization; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D007332:Insulin Infusion Systems; D008297:Male; D008875:Middle Aged
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin